Core Laboratories Inc (CLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 30,391 | 32,153 | 37,025 | 19,658 | 20,219 |
| Depreciation Amortization | 14,649 | 14,953 | 15,784 | 17,161 | 18,516 |
| Income taxes - deferred | 1,420 | 674 | -10,811 | 433 | 6,012 |
| Accounts receivable | -4,953 | -3,612 | -2,618 | -10,078 | -13,522 |
| Accounts payable and accrued liabilities | 477 | 519 | -12,878 | 15,374 | 6,568 |
| Other Working Capital | -14,530 | 7,879 | -28,772 | -25,019 | -20,563 |
| Other Operating Activity | 9,577 | 3,822 | 27,059 | 7,427 | 19,349 |
| Operating Cash Flow | $37,031 | $56,388 | $24,789 | $24,956 | $36,579 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -11,573 | -11,292 | -10,094 | -8,327 | -12,861 |
| Net Acquisitions | -1,237 | N/A | N/A | 240 | 873 |
| Purchase Sale Intangibles | -150 | 20 | 67 | -29 | -318 |
| Other Investing Activity | 10,579 | 4,898 | 3,442 | 4,231 | 1,765 |
| Investing Cash Flow | $-2,231 | $-6,394 | $-6,652 | $-3,856 | $-10,223 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 48,000 | 44,000 | 202,000 | 116,000 | 155,000 |
| Debt Repayment | -63,000 | -82,000 | -211,000 | -131,000 | -226,000 |
| Common Stock Issued | N/A | N/A | N/A | N/A | 60,000 |
| Common Stock Repurchased | -12,426 | -5,306 | -2,202 | -3,903 | -8,256 |
| Dividend Paid | -1,869 | -1,876 | -1,868 | -1,853 | -1,834 |
| Other Financing Activity | -1,960 | -775 | -5,375 | -2,619 | -1,369 |
| Financing Cash Flow | $-31,255 | $-45,957 | $-18,445 | $-23,375 | $-22,459 |
| Beginning Cash Position | 19,157 | 15,120 | 15,428 | 17,703 | 13,806 |
| End Cash Position | 22,702 | 19,157 | 15,120 | 15,428 | 17,703 |
| Net Cash Flow | $3,545 | $4,037 | $-308 | $-2,275 | $3,897 |
| Free Cash Flow | |||||
| Operating Cash Flow | 37,031 | 56,388 | 24,789 | 24,956 | 36,579 |
| Capital Expenditure | -14,589 | -13,028 | -10,579 | -10,216 | -13,539 |
| Free Cash Flow | 22,442 | 43,360 | 14,210 | 14,740 | 23,040 |